Bizarre Patents
Cloaking System Using Optoelectronically Controlled Camouflage
A Cloaking System designed to operate in the visible light spectrum, utilizes optoelectronics and/or photonic components to conceal an object within it.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6902741 | Laminates containing an active substance transdermal system The transdermal system includes a sex hormone-containing adhesive matrix, which contains inclusions of a sex hormone in a hydrophilic non-crosslinked polymer in dissolved or dispersed form. The inclusions have a concentration of 20 to 90 percent by weight of the sex... | 06/07/2005 |
| 6902742 | Multiparticulate modified release composition The invention relates to a multiparticulate modified release composition that in operation delivers an active ingredient in a pulsed or bimodal manner. The multiparticulate modified release composition comprises an immediate release component and a modified release ... | 06/07/2005 |
| 6902739 | Methods for treating joint inflammation, pain, and loss of mobility This invention provides methods and formulations for treating an inflammatory disease or reducing an inflammatory reaction comprising administering a fortified formulation comprising stabilized rice bran derivative and a fortification agent. Preferred rice bran deri... | 06/07/2005 |
| 6899891 | Nutritional composition, methods of producing said composition and methods of using said composition Nutritional compositions comprising at least one of aloe vera, hydrolyzed collagen, garcinia cambogia, chromium polynicotinate, chromium picolinate, chromium cruciferate, conjugated linoleic acid, fiber and natural amino acids are disclosed. Nutritional compositions... | 05/31/2005 |
| 6896903 | Bioadhesive compositions A bioadhesive composition formed by polymerizing a homogeneous aqueous reaction mixture comprising from about 5% to about 50%, by weight of the reaction mixture, of at least one ionic water soluble monomer, from about 10% to about 50%, by weight of the reaction mixt... | 05/24/2005 |
| 6894136 | Mold inhibitor integrated within a matrix and method of making same The invention provides a composition useful in the construction industry for the prevention or remediation of mold growth in a man made structure. The composition contains an extruded milo matrix incorporating terpenes, phytoalexins, calcium propionate or combinatio... | 05/17/2005 |
| 6893662 | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures The present invention relates to a pharmaceutical composition in a solid unit dosage form for oral administration in a human or lower animal comprising: a. a safe and effective amount of a therapeutically active agent; b. an inner coating layer selected from the gro... | 05/17/2005 |
| 6893665 | Formulations for treating or preventing mucositis Mucositis is treated and/or prevented by administrating to a patient a formulation comprising a tetracycline that is poorly absorbed from the gastro-intestinal tract. The tetracycline may be in the form of a pharmaceutically acceptable salt or a base. The formulatio... | 05/17/2005 |
| 6893654 | Two-stage transmucosal medicine delivery system for symptom relief A two-stage medicine delivery system provides an initial dose of medicine and a second dose of medicine. The initial and second doses are capable of achieving a rapid pharmacological effect and a prolonged pharmacological effect, respectively. The two-stage medicine... | 05/17/2005 |
| 6893645 | Process to make a sustained release formulation This invention pertains to a process for making a sustained release complex. Compound (I), which comprises Compound (A), having formula (A), and a copolymer comprising poly (l)-lactic-glycolic-tartaric acid (P(I)LGT), wherein the amino group of Compound (A) is ionic... | 05/17/2005 |
| 6893648 | Composition and method for treatment of vaginal dryness Compositions in gel form or suppository are provided for treatment of vaginal dryness, wherein the composition comprises certain herbal compounds, with or without a vitamin such as, for example, vitamin A, C, D or E. The compositions may include an anti-bacterial ag... | 05/17/2005 |
| 6893652 | Endoparasiticidal gel composition A homogenous, clear, veterinary gel composition which has a broad spectrum of efficacy against endoparasites over a prolonged period of time and which allows for higher concentrations of a mixture of parasiticidal agents in a single application. This composition is ... | 05/17/2005 |
| 6891037 | Method for the isolation of polysaccharides The invention relates to a method for the isolation of polysaccharides, in particular for the separation of endotoxins from capsule polysaccharides of gram-negative bacteria. The polysaccharides isolated by this method are preferably used for the production of polys... | 05/10/2005 |
| 6890522 | Cosmetic and personal care compositions Cosmetic or personal care compositions, such as for styling hair, comprise a thermoplastic elastomer which is a block copolymer comprising a core polymer having a backbone comprising at least a proportion of C—C bonds and two or more flanking polymers. Each flanki... | 05/10/2005 |
| 6890552 | Manufacturing therapeutic enclosures Devices and methods for enhancing the healing of wounds, especially chronic wounds (e.g., diabetic wounds), involving the use of keratinocytes are described. Keratinocytes are grown on a transplantable solid support (e.g., collagen-coated beads), and the keratinocyt... | 05/10/2005 |
| 6887493 | Multi component controlled release system for oral care, food products, nutraceutical, and beverages The present invention relates to an improved controlled release system that can encapsulate different flavors, sensory markers, and active ingredients, or combinations of flavors, sensory markers and various active ingredients and release multiple active ingredients... | 05/03/2005 |
| 6884518 | Material suitable for an individual's tissue reconstruction A material suitable for the reconstruction of an individual's tissue, particularly supportive tissue such as bone tissue, insertable into the tissue. The material is characterized by being composed of wood heat-treated within the temperature range of 100-220° C. in... | 04/26/2005 |
| 6884434 | Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof A transdermal therapeutic system, comprising a backing layer inert to the components of the matrix, a self-adhesive matrix layer containing (−)-5,6,7,8-tetrahydro-6-[propyl-[2-(2-thienyl)ethyl]amino]-1-naphthalenol in an effective amount and a protective foil or s... | 04/26/2005 |
| 6884778 | Biocompatible macromers A new oligomer based on alternating fumaric acid and poly(ethylene glycol) (PEG) units is provided. The oligo(PEG fumarate) (OPF) may be functionalized by modification with a biocompatible organic group. Further, the OPF may be cross-linked using radical polymerizat... | 04/26/2005 |
| 6878384 | Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use Hydrogels that expand volumetrically in response to a change in their environment (e.g., a change in pH or temperature) and their methods of manufacture and use. Generally, the hydrogels are prepared by forming a liquid reaction mixture that contains a) monomer(s) a... | 04/12/2005 |
| 6875441 | Composition for delivery of hematopoietic growth factor A hematopoietic growth factor delivery composition includes a hematopoietic growth factor, a liquid vehicle, a first biocompatible polymer and a second biocompatible polymer. The composition exhibits reverse-thermal viscosity behavior, due to interaction between the... | 04/05/2005 |
| 6875446 | Method for prophylaxis and/or treatment of thromboembolism A new oral IR formulation in solid form for a low molecular weight thrombin inhibitor having pH dependant dissolution, characterized in that the formulation comprises a filler or a combination of fillers having disintegrant properties in an amount higher than 35% w/... | 04/05/2005 |
| 6863902 | Immediate release eplerenone compositions The invention relates to oral pharmaceutical compositions useful as aldosterone receptor blockers comprising the active agent micronized eplerenone in an amount of about 10 mg to about 1000 mg and one or more carrier materials. ... | 03/08/2005 |
| 6858229 | In situ forming hydrogels The invention features materials and methods for the liquid to solid transition of an injectable pre-hydrogel composition to a hydrogel. These methods can be carried out in situ. ... | 02/22/2005 |
| 6855333 | Stabilization of solid thyroid drug formulations Pharmaceutical formulations and dosage forms are provided having improved stability to moisture-induced degradation when compared with conventional dosage forms, especially tablets. The invention features low compression forms of thyroid drugs together with excipien... | 02/15/2005 |
| 6846837 | Topical administration of basic antifungal compositions to treat fungal infections of the nails Methods and topical pharmaceutical formulations are provided for the treatment of nail fungus (onychomycosis). The invention involves a pharmacologically active antifungal agent, plus a pharmaceutically acceptable base in a formulation having a pH of 7.5 to about 13... | 01/25/2005 |
| 6846491 | Clear, polymeric gel composition and method for producing the same Disclosed is a clear, crosslinked, polymeric gel composition that is the reaction product of a microemulsion containing (a) from 1-70 wt. %, preferably from 1-40 wt. %, and more preferably from 10-25 wt. % of an anhydride functionalized polymer, (b) from 0.1-40 wt. ... | 01/25/2005 |
| 6846495 | Compositions having improved delivery of actives The present invention pertains to compositions having improved delivery of pharmaceutical actives. These compositions comprise pharmaceutical actives in an anhydrous solvent. These compositions may take the form of liquid elixirs placed into the mouth and eventually... | 01/25/2005 |
| 6844005 | Electrostatically charged nasal application product with increased strength The present invention relates to a nasal topical application product for restricting the flow of airborne contaminants into a human nasal passage by creation of a proximate, enhanced electrostatic field. This nasal application product includes: (a) a plurality of ma... | 01/18/2005 |
| 6841393 | Selective removal of contaminants from a surface using colored particles and articles having magnets A system and method for removing contaminants from a surface. The system is designed to use very small particles having means thereon which are capable of selectively binding to a contaminant or contaminants of interest. The particles may contain a dye to render the... | 01/11/2005 |
| 6841574 | Topical stabilized prostaglandin E compound dosage forms Compounds of prostaglandin E group (PGE compounds) are stabilized as non-aqueous compositions that include the compound together with a bulking agent that can be a non-aqueous liquid or a solid in a sheet, film or powder form. The composition can optionally include ... | 01/11/2005 |
| 6841168 | Method for the preservation of biologically-active material Biologically-active material can be preserved by a method of desiccation, without lyophilisation, in a matrix of glassy trehalose. The method involves forming a coacervate of the biologically-active material and chitosan and then dehydrating mixture of coacervate an... | 01/11/2005 |
| 6838093 | System for osmotic delivery of pharmaceutically active agents An osmotic system for delivering a pharmaceutically active agent which comprises a core portion, a layer portion enclosing the core portion, and a semipermeable wall portion enclosing the core portion and the layer portion. The core portion includes the pharmaceutic... | 01/04/2005 |
| 6835386 | Collar containing a novel gel formulation to control arthropod infestation of animals The present invention provides a device, preferably a collar or ear tag, capable of the controlled, sustained release of an effective amount of an active ingredient that can protect an animal against arthropod pests, comprising a reservoir containing a novel gel for... | 12/28/2004 |
| 6830759 | Antidiabetic preparation for oral administration There is provided a single preparation which directly decreases both of the post prandial blood glucose level and the fasting blood glucose level close to normal levels, by release-sustaining a drug capable of decreasing the post prandial blood glucose level of diab... | 12/14/2004 |
| 6828412 | Degradable polymers A polymer comprising: a polymeric backbone comprising at least one unit having the structure (I), wherein R-R4 comprise groups selected from the group consisting of H, C1-C12 alkyl, C6-C18 aryl, C7-C | 12/07/2004 |
| 6827930 | System for attracting fish A sport fishing system having: a rod and reel, including fishing line; at least one fishing lure or natural bait; and a controlled released fish attractant for applying to the fishing lure or natural bait. The system may further include an applicator for applying th... | 12/07/2004 |
| 6824792 | Bioadhesive composition This invention relates to a method of producing a bioadhesive composition comprising the steps of preparing a solution of a solvent and a polymer mixture wherein the polymer mixture comprises at least one natural or synthetic polycarboxylated polymer and at least on... | 11/30/2004 |
| 6824787 | Urea and nitrogen based compounds as feeding stimulants/aggregants and masking agents of unpalatable chemicals for subterranean termites Nitrogen containing compounds are effective as subterranean termite feeding stimulants/aggregants and as masking agents for concealing the presence of other compounds which are repellents to termites, when they are used in low concentrations, less than or equal to a... | 11/30/2004 |
| 6818224 | Use of gellable pharmaceutical compositions in periodontology A method is described for preparing a fluid pharmaceutical composition which allows the controlled release of at least one active substance. The method involves mixing a therapeutically effective amount of at least one active substance, from 3 to 55% by weight of ph... | 11/16/2004 |
